Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hims & Hers Health Inc.

57.15
-0.4100-0.71%
Post-market: 56.75-0.4000-0.70%19:59 EDT
Volume:34.45M
Turnover:1.99B
Market Cap:12.79B
PE:83.82
High:59.90
Open:56.30
Low:56.19
Close:57.56
Loading ...

BRIEF-Hims & Hers Health Q1 Revenue USD 586 Million Vs. IBES Estimate USD 538.2 Million

Reuters
·
06 May

Hims & Hers Health Inc - Affirms 2025 Revenue Guidance of $2.3-$2.4 Billion

THOMSON REUTERS
·
06 May

Hims & Hers Health Inc Outlook Q2 Revenue of $530 Million to $550 Million

THOMSON REUTERS
·
06 May

Hims & Hers Health Inc Q2 REV View $564.6 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
06 May

Hims & Hers Health, Inc. Reports First Quarter 2025 Financial Results

Business Wire
·
06 May

Stock Track | Hims & Hers Health Soars 5.34% as Amazon Veteran Joins as COO

Stock Track
·
06 May

Hims & Hers Health Names Nader Kabbani COO

MT Newswires Live
·
05 May

Hims & Hers Health Taps Amazon Executive as Operating Chief

Dow Jones
·
05 May

Hims & Hers Appoints Global Operations Expert and Amazon Veteran as Chief Operations Officer

Business Wire
·
05 May

Why Hims & Hers Health, Inc. (HIMS) Soared Last Week

Insider Monkey
·
04 May

Why Hims & Hers Health, Inc. (HIMS) Went Up On Friday

Insider Monkey
·
03 May

Three High Growth Companies Insiders Are Eager To Hold

Simply Wall St.
·
03 May

Can Sustained Product Demand Drive HIMS Stock Before Q1 Earnings?

Zacks
·
02 May

Hims & Hers Health (NYSE:HIMS) Surges 24% In One Week After Novo Nordisk Partnership

Simply Wall St.
·
02 May

Stock Track | Hims & Hers Health Soars 5.05% on CVS-Novo Nordisk Partnership News

Stock Track
·
01 May

Stock Track | Hims & Hers Health Soars 5.05% as Weight-Loss Drug Partnership Boosts Investor Confidence

Stock Track
·
01 May

CVS posts Q1 earnings beat, raises full-year guidance

Yahoo Finance
·
01 May

Buy Hims (HIMS) or Novo Nordisk (NVO) Stock After Partnership Announcement?

Zacks
·
01 May

Hims & Hers vs. Teladoc: Which Telehealth Stock Is the Better Buy Now?

Zacks
·
01 May

Stock Track | Hims & Hers Health Plummets 5.19% as Novo Nordisk's Wegovy Deal May Not Be Enough to Beat Competition

Stock Track
·
30 Apr